Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
110980901000001112 | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
110981001000001115 | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Has VMP | True | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Inferred relationship | Existential restriction modifier | |
Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 15 dual dose sachet | Has VMP | True | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Inferred relationship | Existential restriction modifier | |
Gaviscon Infant oral powder sachets (Reckitt Benckiser Plc) | Is a | True | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets